This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Daniël de Galle | |
|---|---|
| Name | Daniël de Galle |
Daniël de Galle
Daniël de Galle is a contemporary scientist and academic noted for contributions to analytical chemistry, mass spectrometry, and metabolomics. He has been associated with major institutions and collaborative projects linking University of Ghent, University of Cambridge, European Molecular Biology Laboratory, Max Planck Society and international consortia such as Human Proteome Organization and Metabolomics Society. His work intersects techniques developed at Thermo Fisher Scientific, instrumentation used at European XFEL, and standards promoted by bodies including International Organization for Standardization and International Union of Pure and Applied Chemistry.
Born and raised in Belgium, de Galle completed early studies at institutions connected to Ghent University and regional schools linked to Flemish Community. He pursued undergraduate training at Ghent University where he studied chemistry and engaged with laboratories affiliated with VIB and Institute of Oncology Research. For doctoral studies he enrolled in a joint program influenced by collaborations between Ghent University, KU Leuven, and the Vrije Universiteit Brussel, receiving mentorship from scholars who had ties to Max Planck Institute for Biochemistry and European Molecular Biology Laboratory. During this period he undertook research visits to facilities such as École Polytechnique Fédérale de Lausanne and University of Oxford, working on projects that bridged the portfolios of Agilent Technologies and Bruker instrumentation.
De Galle established a research group focused on coupling high-resolution mass spectrometry with chromatographic separation and bioinformatic workflows, building collaborations with teams at University of Cambridge, University of Oxford, Imperial College London, Karolinska Institutet, and laboratories within the European Molecular Biology Laboratory. He held appointments at departments that collaborate with Wellcome Trust consortia, European Framework programs such as Horizon 2020, and networks coordinated by European Research Council. His laboratory worked closely with core facilities supported by Flemish Government and partnerships with industry groups including Thermo Fisher Scientific, Agilent Technologies, and Waters Corporation to validate methods used in studies of pharmaceuticals, environmental chemistry, and clinical metabolomics.
His research program emphasized methodological rigor and standardization in mass spectrometry workflows, contributing to multicenter studies coordinated with Human Proteome Organization, Metabolomics Society, and interlaboratory exercises involving National Institute of Standards and Technology and national metrology institutes. De Galle’s teams collaborated on projects with clinical partners at Ghent University Hospital, public health agencies such as European Centre for Disease Prevention and Control, and consortia including International Agency for Research on Cancer focusing on biomarkers, exposome research, and translational applications of analytical chemistry.
De Galle authored and coauthored a substantial body of work addressing liquid chromatography–mass spectrometry (LC–MS) method development, data processing, and validation frameworks aligned with guidelines from International Conference on Harmonisation and Food and Drug Administration. His publications included benchmark studies comparing platforms from Thermo Fisher Scientific, Waters Corporation, Agilent Technologies, and Bruker using standardized reference materials provided by National Institute of Standards and Technology and collaborative materials from Human Proteome Organization. He contributed to consensus papers and technical white papers produced alongside groups at European Bioinformatics Institute, Swiss Institute of Bioinformatics, and ProteomeXchange to improve data sharing and annotation standards.
Notable papers from de Galle’s group addressed unbiased metabolite identification strategies integrating databases such as PubChem, ChemSpider, HMDB and ontologies maintained by Gene Ontology and ChEBI, while proposing workflows compatible with repositories like MetaboLights and PRIDE (archive). He played a role in multicenter studies investigating environmental contaminants in human cohorts recruited through collaborations with European Prospective Investigation into Cancer and Nutrition and clinical studies coordinated with European Society of Cardiology investigators. His methodological innovations influenced guidelines from International Organization for Standardization and methodological frameworks adopted by Clinical and Laboratory Standards Institute.
De Galle received recognition from professional societies and funding bodies including awards and grants from European Research Council, fellowships associated with Flemish Research Foundation and honors from the Metabolomics Society. He was invited to present keynote lectures at conferences organized by Human Proteome Organization, American Society for Mass Spectrometry, and Euromass. His work earned citations in policy documents from European Commission research initiatives and acknowledgment in collaborative award citations from institutions such as Ghent University and regional science prize committees linked to the Flemish Government.
Outside the laboratory, de Galle engaged in outreach and training programs in partnership with Metabolomics Society, International Mass Spectrometry Foundation and educational initiatives connected to Ghent University Hospital and regional schools. His legacy includes a generation of trainees who took positions at institutions including Karolinska Institutet, Imperial College London, University of California, San Diego, and industry roles at Thermo Fisher Scientific and Agilent Technologies. He is cited in methodological chapters of textbooks used at Ghent University, KU Leuven, and in curricular materials adopted by programs at École Polytechnique Fédérale de Lausanne and University of Cambridge. De Galle’s contributions persist in standardized protocols, open data resources, and cross-disciplinary networks spanning analytical chemistry, clinical research, and environmental health.
Category:Belgian scientists